Dicerna Pharmaceuticals, Inc.

Company Summary

Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases.

Transaction Overview

Significance of the Transaction

The Series C financing permits the Company to expand its specialty contract manufacturing capabilities and broaden existing strategic partnerships with global generics manufacturers

Healthios Role

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Dicerna Pharmaceuticals, Inc.
Has completed a $60,000,000 series C financing led by
The undersigned acted as an exclusive advisor to Dicerna
Read More